You are here: Welcome to the MPKB » Welcome to the MPKB » Resources for physicians
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
home:physicians [12.18.2018] – [Resources for physicians] sallieqhome:physicians [12.18.2018] – [Resources for physicians] sallieq
Line 13: Line 13:
  
 In determining whether a patient can be successfully treated with the MP, a specific chronic disease  In determining whether a patient can be successfully treated with the MP, a specific chronic disease 
-diagnosis is not as important as the clinical assessment by a knowledgeable health care provider, the results of a [[home:starting:therapeutic_probe|therapeutic probe]], and outcome of the [[home:tests:vitdinterpretation|vitamin D metabolites blood test]].(({{pubmed>long:19758177}})) +diagnosis is not as important as the clinical assessment by an interested health care provider, the results of a [[home:starting:therapeutic_probe|therapeutic probe]], and outcome of the [[home:tests:vitdinterpretation|vitamin D metabolites blood test]].(({{pubmed>long:19758177}})) 
  
 According to the Marshall Pathogenesis, chronic inflammatory disease is characterized by dysregulation of the nuclear receptor pathways which control the innate immune response. For example, the Vitamin D nuclear receptor (VDR) expresses many of the body's antimicrobial peptides (along with TLR2). In addition to down-regulation of expression of the VDR itself by many common bacteria and viruses, antagonistic microbial metabolites incrementally block ligands from activating it. Ingested vitamin D slows activity of the receptor in this same manner, preventing the body from killing the pathogens at the heart of the disease state.  That is why avoidance of ingested vitamin D (in food and supplements) is essential for the innate immune system to function correctly while patients are on the MP.(({{pubmed>long:19393200}})) ((Waterhouse JC, Marshall TG, Fenter B, Mangin M, Blaney G. [[home:publications:waterhouse_new_research_2006|High levels of active 1,25-dihydroxyvitamin D despite low levels of the 25-hydroxyvitamin D precursor — Implications of dysregulated vitamin D for diagnosis and treatment of Chronic Disease]]. In //Vitamin D: New Research//.  According to the Marshall Pathogenesis, chronic inflammatory disease is characterized by dysregulation of the nuclear receptor pathways which control the innate immune response. For example, the Vitamin D nuclear receptor (VDR) expresses many of the body's antimicrobial peptides (along with TLR2). In addition to down-regulation of expression of the VDR itself by many common bacteria and viruses, antagonistic microbial metabolites incrementally block ligands from activating it. Ingested vitamin D slows activity of the receptor in this same manner, preventing the body from killing the pathogens at the heart of the disease state.  That is why avoidance of ingested vitamin D (in food and supplements) is essential for the innate immune system to function correctly while patients are on the MP.(({{pubmed>long:19393200}})) ((Waterhouse JC, Marshall TG, Fenter B, Mangin M, Blaney G. [[home:publications:waterhouse_new_research_2006|High levels of active 1,25-dihydroxyvitamin D despite low levels of the 25-hydroxyvitamin D precursor — Implications of dysregulated vitamin D for diagnosis and treatment of Chronic Disease]]. In //Vitamin D: New Research//. 
home/physicians.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.